#Jan Aushadhi Kendra

[bhaskarlive]

PM Modi to launch Jan Aushadhi Kendra at AIIMS in New Delhi on Oct 29

Prime Minister Narendra Modi will inaugurate a new Jan Aushadhi Kendra at the All India Institute of Medical Sciences (AIIMS) in the national capital on Tuesday.

PM Modi will inaugurate this Kendra in the presence of J.P. Nadda, Union Minister of Health and Family Welfare.

Source: bhaskarlive.in

[townpostin]

Deputy Commissioner Reviews Cooperative Schemes for East Singhbhum

Focus on Self-Reliance in Fisheries and Milk Production Through Cooperative Societies Meeting outlines plans for warehouse construction and expansion of cooperative initiatives. JAMSHEDPUR – Deputy Commissioner Ananya Mittal chaired a crucial review meeting of cooperative departmental schemes, emphasizing the district’s path to self-reliance in fisheries and milk production. "Our goal is to…

[drbestchd]

Diet Chart For Thyroid Patient | Thyroid

Diet Chart | Dr Best Pharmaceuticals

If You Follow This Diet Plan You Will Never Have Thyroid Problem!!!

The thyroid is a small, butterfly-shaped gland located in the front of the neck, just below the Adam's apple. Despite its modest size, this gland plays a crucial role in regulating various bodily functions through the production of thyroid hormones. These hormones, namely thyroxine (T4) and triiodothyronine (T3), influence metabolism—the process by which the body converts food into energy.

The thyroid's activity is controlled by the pituitary gland, which releases thyroid-stimulating hormone (TSH). When the thyroid receives this signal, it produces and releases T3 and T4 into the bloodstream. These hormones help regulate the body's temperature, heart rate, and energy levels, impacting functions such as growth and development, digestion, and muscle control.

Imbalances in thyroid hormone levels can lead to health issues. Hypothyroidism occurs when the thyroid produces insufficient hormones, causing fatigue, weight gain, and cold sensitivity. In contrast, hyperthyroidism results from an excess of thyroid hormones, leading to symptoms like weight loss, rapid heartbeat, and heat intolerance.

Regular check-ups and medical attention can help diagnose and manage thyroid disorders, ensuring the gland functions optimally and maintains overall well-being.

Read Full Blog Here: Diet Chart For Thyroid Patient | Thyroid Diet Chart | Dr Best Pharmaceuticals

Here is a 7-Day Diet Plan for Thyroid Patients:

Day 1Breakfast: Vegetable poha + Skimmed milk Morning Snack: Sliced papaya Lunch: Roti + Palak dal + Ajwain jeera tomato rice Evening Snack: Sprouted black chana chaat Dinner: Steamed fish in banana leaf + Stir fried vegetables in olive oil + Rice flakes upma

Day 2:Breakfast: Chola bhature (with whole wheat bhatura) + Mint raita Morning Snack: Buttermilk Lunch: Khichdi + Pickle + Cucumber raita Evening Snack: Strawberry lassi (unsweetened) Dinner: Grilled paneer tikka+ Chickpea salad + Quinoa

Day 3:Breakfast: Masala oats + Milk Morning Snack: Fruit custard Lunch: Moong dal khichdi + Spinach paneer + Beetroot salad Evening Snack: Yogurt curry + Jowar chapati Dinner: Chicken curry+ Brown rice + Veggies stir fry

Day 4:Breakfast: Poha upma + Peanuts Morning Snack: Banana date smoothie Lunch: Rajma chawal + Methi thepla + Kaddu raita Evening Snack: Mixed veggie poha Dinner: Prawn malai curry + Palak dal + Jeera aloo + Rice

Day 5:Breakfast: Stuffed paratha + Cucumber raita Morning Snack: Foxnuts chaat Lunch: Chana dal fry + Zucchini subzi + Methi muthia + Jeera rice Evening Snack: Veg sandwich + Celery sticks Dinner: Mushroom matar masala + Tilapia fish fry + Quinoa salad

Day 6:Breakfast: Paneer besan chilla + Tomato coriander chutney Morning Snack: Sprouted salad chaat Lunch: Rajma salad + Missi roti Evening Snack: Roasted makhana Dinner: Egg curry + Broccoli potato fry + Broken wheat khichdi

Day 7:Breakfast: Poha masala + Chana dal vada + Kokum sherbet Morning Snack: Watermelon cubes Lunch: Dal fry + Baingan masala + Brown rice Evening Snack: Idli with chutney Dinner: Chicken/paneer tikka masala + Stir fried veggies + Beans salad

Read Full Blog Here: Diet Chart For Thyroid Patient | Thyroid Diet Chart | Dr Best Pharmaceuticals

[news365timesindia]

[ad_1] Prime Minister Narendra Modi on Wednesday announced plans to boost India’s pharmaceutical exports to Guyana and establish ‘Jan Aushadhi Kendras’ in the Caribbean nation, aiming to enhance access to affordable medicines. Addressing a joint press conference with President Ali, PM Modi underscored the growing partnership between the two countries, highlighting collaborations in defense, food security, and energy security. Addressing the press meet with President Dr. Irfaan Ali of Guyana. @presidentaligy https://t.co/4buBohkUL4 — Narendra Modi (@narendramodi) November 20, 2024 PM Modi on Wednesday described his visit to Guyana, the first by an Indian Prime Minister in 56 years, as a “significant milestone” in strengthening ties between the two nations. Expressing his gratitude to Guyana’s President Irfaan Ali for the warm reception, PM Modi highlighted his personal connection to the country, recalling a visit 24 years ago as a regular citizen. PM Modi said, “I thank President Dr Irfaan Ali for the grand welcome. It is a significant milestone that an Indian PM has come here after 56 years. I have a personal connection with Guyana. 24 years ago, I had the opportunity to come here as an ordinary citizen. Today, I am fortunate to come here as a Prime Minister.” #WATCH | Georgetown, Guyana: PM Modi says, “… I thank President Dr Irfaan Ali for the grand welcome. It is a milestone that an Indian PM has come here after 56 years. I have a personal connection with Guyana. 24 years ago, I had the opportunity to come here… Today, I am… pic.twitter.com/rvuFizG6VM — ANI (@ANI) November 20, 2024 The Prime Minister highlighted the enduring bond between India and Guyana, rooted in the shared heritage of the Indian diaspora, which has contributed significantly to Guyana’s development over the past 180 years. President Ali, who has been a vocal advocate for strengthening ties with India, hailed PM Modi’s visit as a testament to the deep friendship between the two nations. During their talks, PM Modi reiterated the importance of addressing global challenges through diplomacy and dialogue. Both leaders called for reforms in international institutions to better address modern complexities, reflecting their shared vision for a more equitable world order. PM Modi’s state visit was marked by significant honors, including a ceremonial welcome, a Guard of Honour, and the presentation of the ‘Key to the City of Georgetown.’ #WATCH | Prime Minister Narendra Modi tweets the highlights from yesterday’s welcome in Guyana (Source: PM Modi/X) pic.twitter.com/dMm2g9z7kC — ANI (@ANI) November 20, 2024 Click here for Latest Fact Checked News On NewsMobile WhatsApp Channel For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram [ad_2] Source link

[news365times]

[ad_1] Prime Minister Narendra Modi on Wednesday announced plans to boost India’s pharmaceutical exports to Guyana and establish ‘Jan Aushadhi Kendras’ in the Caribbean nation, aiming to enhance access to affordable medicines. Addressing a joint press conference with President Ali, PM Modi underscored the growing partnership between the two countries, highlighting collaborations in defense, food security, and energy security. Addressing the press meet with President Dr. Irfaan Ali of Guyana. @presidentaligy https://t.co/4buBohkUL4 — Narendra Modi (@narendramodi) November 20, 2024 PM Modi on Wednesday described his visit to Guyana, the first by an Indian Prime Minister in 56 years, as a “significant milestone” in strengthening ties between the two nations. Expressing his gratitude to Guyana’s President Irfaan Ali for the warm reception, PM Modi highlighted his personal connection to the country, recalling a visit 24 years ago as a regular citizen. PM Modi said, “I thank President Dr Irfaan Ali for the grand welcome. It is a significant milestone that an Indian PM has come here after 56 years. I have a personal connection with Guyana. 24 years ago, I had the opportunity to come here as an ordinary citizen. Today, I am fortunate to come here as a Prime Minister.” #WATCH | Georgetown, Guyana: PM Modi says, “… I thank President Dr Irfaan Ali for the grand welcome. It is a milestone that an Indian PM has come here after 56 years. I have a personal connection with Guyana. 24 years ago, I had the opportunity to come here… Today, I am… pic.twitter.com/rvuFizG6VM — ANI (@ANI) November 20, 2024 The Prime Minister highlighted the enduring bond between India and Guyana, rooted in the shared heritage of the Indian diaspora, which has contributed significantly to Guyana’s development over the past 180 years. President Ali, who has been a vocal advocate for strengthening ties with India, hailed PM Modi’s visit as a testament to the deep friendship between the two nations. During their talks, PM Modi reiterated the importance of addressing global challenges through diplomacy and dialogue. Both leaders called for reforms in international institutions to better address modern complexities, reflecting their shared vision for a more equitable world order. PM Modi’s state visit was marked by significant honors, including a ceremonial welcome, a Guard of Honour, and the presentation of the ‘Key to the City of Georgetown.’ #WATCH | Prime Minister Narendra Modi tweets the highlights from yesterday’s welcome in Guyana (Source: PM Modi/X) pic.twitter.com/dMm2g9z7kC — ANI (@ANI) November 20, 2024 Click here for Latest Fact Checked News On NewsMobile WhatsApp Channel For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram [ad_2] Source link

[franchise-discovery-blog]

Looking to start your own business with a trusted name? Check out the Top Government Franchise Brands in India! 🇮🇳✨

→ India Post: Largest postal network. → Jan Aushadhi Kendra: Affordable medicines. → Indian Oil Corporation: Trusted fuel brand. And more..

Explore these options and take the first step toward your dream business! 💼

[siddhiktimes]

PM Jan Aushadhi Kendra: देशवासियों के जीवन को और ज्यादा सुलभ करने के लिए सरकार ने बड़ी पहल की है और प्रधानमंत्री जन औषधि केंद्र (PM Jan Ausadhi Kendra) खोलने वाले युवाओं को 2 लाख रुपए तक की आर्थिक मदद करने का ऐलान किया है । इससे न केवल जरूरतमंदों को कम पैसों में जेनेरिक दवाइयां (Generic Medicines) मिलेंगी बल्कि एक अच्छ रोजगार का अवसर भी पैदा होगा।

[sharpbharat]

Jamshedpur rural jan aushadhi  Kendra : गालूडीह के बागालगोड़ा में खुला जन औषधि सेवा केंद्र, पंचायत की मुखिया आशा सिंह ने फीता का�� कर किया उद्घाटन

गालूडीह : जोड़िसा पंचायत के बगालगोड़ा गांव में जगदीश महतो के घर पर गुरुवार को जन औषधि सेवा केंद्र की शुरुआत हुई. पंचायत की मुखिया आशा सिंह ने फीता काट कर जन औषधि केंद्र का फीता काटकर विधिवत उद्घाटन किया. मालूम हो कि राज्य सरकार के द्वारा हर पंचायत में जन औषधि सेवा केंद्र नाम से दवा दुकान का लाइसेंस देने की घोषणा की गई थी. उसी के तहत दवा दुकान का उद्घाटन किया गया. (नीचे भी पढ़ें) इस दवा दुकान के…

[manishprajapati3311]

Poor, middle class people in India have immensely benefited from Jan Aushadhi Kendras : PM #Modi

[financelatestnews]

How To Apply For Pradhan Mantri Jan Aushadhi Kendra?

In India, quality healthcare services are still out of reach of millions, mostly in rural areas, due to the high cost of branded medicines and surgical consumables, thus making them vulnerable to common diseases that can be easily treated.

Therefore, to help reach affordable and quality healthcare services to people living in rural and semi-rural regions, the Indian government through its flagship program- Pradhan Mantri Jan Aushadhi Yojana-  aims to provide affordable healthcare to the underprivileged.

Pradhan Mantri Jan Aushadhi Yojana (PM-JAY)

The PM-JAY is a Government of India scheme to make healthcare accessible and affordable for every citizen by providing low-cost generic medicines and commonly used surgical consumables through its PM-JAY kendras or stores.

Currently, over 6,500 PM-JAY kendras are functioning all over the country, providing over 8,000 generic medicines and surgical consumables at a lower rate

Who Can Open a PM-JAY Store?

To achieve maximum coverage throughout the country, the Government allows individuals to open PM-JAY kendras and offer lucrative incentives. However, you can open a PM-JAY Kendra, only if:

You are a registered doctor

You are a registered medical practitioner

You are a B.Pharma/ D.Pharma degree holder

You can also open a jan aushadhi kendra if you employ a B.Pharma/D.Pharma degree holder. There is also an opportunity to open a jan aushadhi kendra at the government hospital premise, however, the preference is given to an NGO or charitable trust in this case.

How to Apply for a PM-JAY Store?

The requirements to apply for a jan aushadhi kendra are:

You should have a self-owned or leased shop space of 120 sq ft and above, with all legal documents in place

You will need to provide the name of the pharmacist registered with the state council

If the applicant is from the SC/ST category or differently-abled, he/she needs to provide required certificates as proof

If you fulfill the above-mentioned requirements for the jan aushadhi kendra, apply online today.

Alongside, you can also apply via the offline process, in which you are required to download the Application Form for opening a Pradhan Mantri Bhartiya Janaushadhi Kendra.

You will need to fill the application form and send it to the Bureau of Pharma Public Sector Undertaking of India (BPPI), the implementing agency of PM-JAY at the following address:

To, The CEO, Bureau of Pharma Public Sector Undertakings of India (BPPI), 8th Floor Videocon Tower, Block E1, Jhandewalan Extension, New Delhi – 110055 Tel – 011-49431800

BPPI is responsible for the procurement of generic medicines at lower prices, marketing, distribution, and monitoring of PM-JAY Kendras.

Profits and Incentives

Opening a PM-JAY is a very lucrative business opportunity, as along with earning reasonable profits, you will also play a key role in transforming the healthcare services in India.

Following are the monetary incentives granted to jan aushadhi kendra operator:

A PM-JAY retailer is provided 20% margin on MRP of each generic drug and 10% margin if you are a distributor

If your PM-JAY Kendra is connected to the BPPI systems, you can get up to a maximum of Rs 2.5 lakh of incentives annually. This is calculated 15% on the monthly sales of your store with an upper ceiling of Rs 10,000. For north-eastern states, Naxal-affected and tribal regions, the limit goes up to Rs 15,000.

PM-JAY Kendra operator falling under the category of SC/ST candidate and differently-abled will be given medicines worth Rs 50,000 in advance

The store operator will be provided with a remuneration of Rs 1 lakh on purchase of furniture and fittings and Rs 50,000 on purchase of computer, printer and internet.

2% of total sales or actual loss will be provided against expired medicines. Also, the expired medicines will be considered as a loss for BPPI, not the retailer or distributor

30-days free-credit period will be provided against a post-dated cheque

Therefore, as a retailer, on monthly sales of Rs 1 lakh, you can earn a commission of Rs 20,000 and Rs 10,000 as an incentive. Plus, the establishment cost is also reimbursed by BPPI to a great extent.

PM-JAY offers an excellent opportunity for individuals and doctors in providing affordable medicines to every citizen of India and is also a viable business model. Individuals and doctors with valid licenses to open the shop can also take a loan under personal loan for doctors and business loan for doctors segment to meet the initial Capex requirement.

Both personal loan and business loan provide flexible loan facilities with loan tenure ranging between 12-60 months, with no collateral and online account access to manage and track your loan account anytime, anywhere.

Source URL: https://www.smfgindiacredit.com/knowledge-center/pradhan-mantri-jan-aushadhi-kendra.aspx

[thxnews]

Doctors Urged to Prescribe Generic Medicines

  Ensuring Rational Prescription and Generic Medicines

The Indian government is urging doctors to prescribe generic medicines to promote affordable healthcare and rational prescription practices. Clause 1.5 of the Indian Medical Council (Professional Conduct, Etiquette, and Ethics) Regulations, 2002, mandates physicians to prescribe drugs with generic names legibly, preferably in capital letters, and to ensure rational prescription and use of drugs. The National Medical Commission Act, 2019, empowers the appropriate State Medical Councils or the Ethics and Medical Registration Board (EMRB) of the National Medical Commission to take disciplinary action against doctors for violating these regulations.   Spreading Awareness and Ensuring Compliance To ensure compliance with the regulations and promote the use of generic medicines, more than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJK) have been established across all districts of the country. These centers offer generic medicines at affordable prices, making healthcare accessible to all. The Department of Pharmaceuticals/Pharmaceuticals & Medical Devices Bureau of India (PMBI) is actively spreading awareness about the scheme through various media channels, including electronic and print media, as well as through social media platforms.  

National Health Mission's Support

Under the National Health Mission (NHM), support is provided for the provision of essential generic drugs free of cost in public health facilities. This support extends beyond drugs and includes the necessary components for effective implementation of the Free Drug Service Initiative, such as robust procurement systems, quality assurance, IT-backed supply chain management systems, and training.   Jan Aushadhi Diwas and Janaushadhi Sugam App In addition to the Pradhan Mantri Bhartiya Janaushadhi Kendras, the government celebrates Jan Aushadhi Diwas every year on 7th March to raise awareness about the benefits of generic medicines and the scheme. Furthermore, PMBI maintains a mobile application called Janaushadhi Sugam, a one-stop platform that assists users in locating nearby PMBJK, searching for Janaushadhi medicines, and finding contact details. The push for generic medicines aims to democratize healthcare and ensure that quality medications are accessible to all citizens. By promoting the prescription of generic drugs, the government endeavors to make healthcare more affordable and improve the overall health outcomes for the population. Please Note: The information provided in this article is based on a written reply by the Union Minister of State for Health and Family Welfare, Dr. Bharati Pravin Pawar, in the Lok Sabha.   Sources: THX News & Government of India. Read the full article

[news365timesindia]

Research by Subhash Chandra Agrawal Jan Aushadhi Kendras are now being opened under Pradhan Mantri Bhartiya Janaushadhi Pariyojna claiming a huge saving to commoners ranging from 50-90 percent on purchase of generic medicines from these about 10000 centres throughout the country with average monthly sale of just rupees 1.50 lakhs per month for each centre. Much more could and should be achieved simply by fixing a maximum trade margin on all medicines and medical-consumables including generic medicines of say 30-percent between ex-factory price and Maximum-Retail-Price (MRP). Presently there is a huge trade-margin specially on generic medicines are considered to be economical substitute of branded medicines. A box of 10-20 strips is available with distributors at about one-tenth of printed MRP including those marketed by renowned drug-manufacturers of branded medicines. A box containing 20 strips of ten tablets each of Vogliboz-0.3 tablets marketed by Knoll Healthcare Pvt Ltd with printed Maximum-Retail-Price MRP of rupees 100 each (MRP of complete box rupees 2000) was available with the distributor at just rupees 250 meaning a profit of 700-percent for the retailer. A box of 300 tablets of Lipvas-10 (Atorvastatin) manufactured by Cipla Limited with total MRP rupees 1837.20 was available at rupees 300. A box of 20 strips of ten capsules each with MRP rupees 114 per strip (Total MRP rupees 2280) of Pantosec DSR marketed by Cipla Limited was available at a wholesaler at just rupees 550 meaning thereby a trade-margin of 315-percent. Even wholesalers are at liberty to earn huge by offering just 20-percent discount on printed MRP of Generic Medicines. Same is case with thousands of generic medicines manufactured by various companies Even branded medicines had varying trade-margins with a box of 10 strips of 10 capsules each of Bifilac-HP with total printed MRP of rupees 2100 per box was available with the distributor at just rupees 1140 per box. Even World Health Organization (WHO) established that even essential drugs in India with lowest printed MRP are exorbitantly priced over manufacturing-cost followed by abnormally high trade-margin between ex-factory price and MRP. Same holds good for other medical-consumables like a box of 200 Accu-Check Safe T Pro Uno single-use lancing device with printed MRP of rupees 2200 used to be available at just rupees 400 only. Drug-manufacturers at times pack just eight lozenges per strip of commonly advertised cough-medicines instead of usually ten because consumers usually judge by price per strip rather than per lozenge. Many drug-manufacturers have started packing medicines in strips of fifteen rather than earlier ten to boost up sale because most chemists sell complete medicine-strip rather than cutting the strip to sell in loose. National Pharmaceutical Pricing Authority (NPPA) should direct all medicines to be compulsorily packed in units of 1, 2, 5, 10, 20, 50, 100, 200, 500, 1000 and likewise higher multiples unless permission is sought from concerned authorities to pack certain medicines in units other than these for dose-wise administration. Name of medicine is usually printed just once on a side of medicine-strip. Wrapping-foil must be so designed that name of medicine may appear for each packed tablet/capsule with name of medicine also embossed/printed on each tablet/capsule. Ex-factory prices of different branded medicines for same basic salt has vast difference. Branded medicines from different renowned companies are priced with heavy difference depending on popularity of brand like Calmpose and Valium-5 both having Diazepam-5 as basic salt have huge price-difference. Government-owned Indian Drugs & Pharmaceuticals Limited (IDPL), since closed, sold Diazepam-5 under brand-name Calmod at still lower price. Medicines are put in different categories for price-regulation with Calmpose and Valium-5 put in a category where there is no price-regulation. System of having multiple categorization

for medicines must be removed because patients have to take prescribed medicine irrespective of their categorization. A study conducted by a prominent newspaper in the year 2018 revealed that five chemist-shops around premier Post Graduate Institute of Medical Education and Research (PGIMER) at Chandigarh were selling a particular medicine having price ranging from rupees 255 to rupees 1550. There is a regular price-increase of many branded medicines, with NPPA being mute spectator. NPPA should devise a mechanism whereby drug-companies may be allowed to have some basic profit-margin on all types of drugs irrespective of their categorization allowing any price-revision only once in a year say in January or April every year. Madras High Court once directed Income Tax Department to submit details of claims made by pharmaceutical-companies towards tax-deduction for gifts made to doctors, names of doctors and penalties paid by these companies for drug-overpricing. Any type of gifts by drug-companies must be banned. Paying commission to medical practitioners by pathological laboratories, investigating centers and hospitals should also be criminal offence to ensure economical medical investigations. Private hospitals should be directed not to take any share from consulting/visiting fees of medical practitioners. Some upper limit should be fixed for consultation-fees of medical practitioners. Since wholesale medicine-market of Bhagirath Palace (Delhi) has virtually turned to be a retail market giving 20-25 percent discount even on single strips of medicines, tenders can be invited for opening chemist-shops in government and private hospitals at least in big cities where branded medicines may be available even in single strips at 20-percent discounts. It is quite usual that many a times some medical-practitioners including in Unani, Ayurvedic and Homeopathic fields mix strong doses of allopathic steroids in unbranded medicines like powders and syrups in a bid to exhibit their self-acclaimed expertise in curing diseases. Only branded medicines should be allowed to be prescribed in all fields of medicines including Allopathic, Ayurvedic, Unani, Homeopathy with Central Government having its large production-units for very type of medicines by reviving Indian Drugs & Pharmaceuticals Limited (IDPL) in a big way and popularising and extending scope of its Ayurvedic unit Indian Medicines Pharmaceuticals Corporation Limited to develop a healthy competition to force big drug-companies to bring down heavily prices of branded medicines. Central Information Commission (CIC) in its order dated 01.10.2018 in file-number CIC/NPPAT/A/2017/152869-BJ recommended NPPA and others concerned to consider all these suggestions in larger public interest. But shockingly, NPPA challenged the CIC-decision just on recommendations (and not directions) at Delhi High Court vide WP(C) 10366 of 2019 and CM No. 42777 of 2019. Soon after Competition Commission of India (CCI) in its policy-note also pointed out towards unreasonably high trade-margins as reason for exorbitant drug-prices. But no corrective measures are seen at least on non-essential and generic medicines. BJP MP Bhartruhari Mahtab raised issue of generic drugs in Lok Sabha on 19.07.2019, rightly demanding an inquiry to find out the efficacy of generic drugs quoting a book-study that Indian drug manufacturers were producing quality generic medicines for US and European countries with sub-standard generic medicines marketed in domestic market. NPPA should ensure that generic medicines sold in Indian markets are of export-quality. Export of world-class generic medicines can provide country adequate foreign-exchange and reputation because of Indian generic medicines are economical than foreign-branded medicines of which major part is royalty of drug-manufacturing companies. Lucknow bench of Allahabad High Court in the year 2018 imposed fine on three doctors for illegible hand-writing on injury-reports. Odisha High Court on 13.

08.2020 advised doctors to write legible prescriptions preferably in capital letters. Medical-practitioners should compulsorily issue computerised prescriptions. Exemption may be for aged ones not familiar to use computers. Union Health Ministry should develop user-friendly soft-wares separately for hospitals, pathological laboratories and medical practitioners providing unique ID for each patient so that complete medical history may be available even online to the patient.   Dual pricing must not be allowed in health-services including for pathological and biochemical tests for normal patients and those covered under Central Government Health scheme (CGHS). Vegetarian cellulose capsules should be encouraged to replace non-vegetarian gelatin capsules presently having 98-percent market share to respect sentiments of majority vegetarian population. Supreme Court ruling of the year 2013 had made it possible to distinguish vegetarian and non-vegetarian medicines by having green and red dots. Providing land at subsidised cost/lease is substantial government-funding. All such hospitals should be directed to sue-motto declare themselves as public-authorities under section 2(h) of RTI Act, or else pay market-price of land provided to these hospitals at current market rates. Union Health Ministry in the year 2018 banned 328 Fixed-Dose-Combination drugs out of total 349 recommended to be banned by Chandrashekhar Kokate Committee with six more allowed with restricted sale. Banned medicines included commonly advertised popular medicines like Saridon and Vicks-Action-500 which continued to be household names in India for last so many decades. Medicines considered harmful are banned in India years after these are banned in foreign countries. Union Health Ministry should take immediate decision once some medicine is banned in other countries. Action is necessary against celebrities advertising the popular medicines without having knowledge about the advertised medicines. There should be a total ban on advertisements of medicines in view of ban imposed on commonly advertised medicines. Reports were there in media with opinion of medical experts about artificial health-food and cosmetic surgery being possible reasons behind the cardiac-arrest responsible for sudden untimely death of Bollywood-superstar Shridevi (54) on night of 24.02.2018 at Dubai. Fast life-style has made youngsters to switch to costly gyms from natural walk. Trend of cosmetic surgery for looking beautiful and fit is also increasing with same pace. Union Health Ministry should set up an expert-committee to study after-effects of artificial health-food and cosmetic surgery, and only certified health-food should be permitted to be sold. Writer is RTI consultant holding Guinness World record for most letters published in newspaper

[news365times]

Research by Subhash Chandra Agrawal Jan Aushadhi Kendras are now being opened under Pradhan Mantri Bhartiya Janaushadhi Pariyojna claiming a huge saving to commoners ranging from 50-90 percent on purchase of generic medicines from these about 10000 centres throughout the country with average monthly sale of just rupees 1.50 lakhs per month for each centre. Much more could and should be achieved simply by fixing a maximum trade margin on all medicines and medical-consumables including generic medicines of say 30-percent between ex-factory price and Maximum-Retail-Price (MRP). Presently there is a huge trade-margin specially on generic medicines are considered to be economical substitute of branded medicines. A box of 10-20 strips is available with distributors at about one-tenth of printed MRP including those marketed by renowned drug-manufacturers of branded medicines. A box containing 20 strips of ten tablets each of Vogliboz-0.3 tablets marketed by Knoll Healthcare Pvt Ltd with printed Maximum-Retail-Price MRP of rupees 100 each (MRP of complete box rupees 2000) was available with the distributor at just rupees 250 meaning a profit of 700-percent for the retailer. A box of 300 tablets of Lipvas-10 (Atorvastatin) manufactured by Cipla Limited with total MRP rupees 1837.20 was available at rupees 300. A box of 20 strips of ten capsules each with MRP rupees 114 per strip (Total MRP rupees 2280) of Pantosec DSR marketed by Cipla Limited was available at a wholesaler at just rupees 550 meaning thereby a trade-margin of 315-percent. Even wholesalers are at liberty to earn huge by offering just 20-percent discount on printed MRP of Generic Medicines. Same is case with thousands of generic medicines manufactured by various companies Even branded medicines had varying trade-margins with a box of 10 strips of 10 capsules each of Bifilac-HP with total printed MRP of rupees 2100 per box was available with the distributor at just rupees 1140 per box. Even World Health Organization (WHO) established that even essential drugs in India with lowest printed MRP are exorbitantly priced over manufacturing-cost followed by abnormally high trade-margin between ex-factory price and MRP. Same holds good for other medical-consumables like a box of 200 Accu-Check Safe T Pro Uno single-use lancing device with printed MRP of rupees 2200 used to be available at just rupees 400 only. Drug-manufacturers at times pack just eight lozenges per strip of commonly advertised cough-medicines instead of usually ten because consumers usually judge by price per strip rather than per lozenge. Many drug-manufacturers have started packing medicines in strips of fifteen rather than earlier ten to boost up sale because most chemists sell complete medicine-strip rather than cutting the strip to sell in loose. National Pharmaceutical Pricing Authority (NPPA) should direct all medicines to be compulsorily packed in units of 1, 2, 5, 10, 20, 50, 100, 200, 500, 1000 and likewise higher multiples unless permission is sought from concerned authorities to pack certain medicines in units other than these for dose-wise administration. Name of medicine is usually printed just once on a side of medicine-strip. Wrapping-foil must be so designed that name of medicine may appear for each packed tablet/capsule with name of medicine also embossed/printed on each tablet/capsule. Ex-factory prices of different branded medicines for same basic salt has vast difference. Branded medicines from different renowned companies are priced with heavy difference depending on popularity of brand like Calmpose and Valium-5 both having Diazepam-5 as basic salt have huge price-difference. Government-owned Indian Drugs & Pharmaceuticals Limited (IDPL), since closed, sold Diazepam-5 under brand-name Calmod at still lower price. Medicines are put in different categories for price-regulation with Calmpose and Valium-5 put in a category where there is no price-regulation. System of having multiple categorization

for medicines must be removed because patients have to take prescribed medicine irrespective of their categorization. A study conducted by a prominent newspaper in the year 2018 revealed that five chemist-shops around premier Post Graduate Institute of Medical Education and Research (PGIMER) at Chandigarh were selling a particular medicine having price ranging from rupees 255 to rupees 1550. There is a regular price-increase of many branded medicines, with NPPA being mute spectator. NPPA should devise a mechanism whereby drug-companies may be allowed to have some basic profit-margin on all types of drugs irrespective of their categorization allowing any price-revision only once in a year say in January or April every year. Madras High Court once directed Income Tax Department to submit details of claims made by pharmaceutical-companies towards tax-deduction for gifts made to doctors, names of doctors and penalties paid by these companies for drug-overpricing. Any type of gifts by drug-companies must be banned. Paying commission to medical practitioners by pathological laboratories, investigating centers and hospitals should also be criminal offence to ensure economical medical investigations. Private hospitals should be directed not to take any share from consulting/visiting fees of medical practitioners. Some upper limit should be fixed for consultation-fees of medical practitioners. Since wholesale medicine-market of Bhagirath Palace (Delhi) has virtually turned to be a retail market giving 20-25 percent discount even on single strips of medicines, tenders can be invited for opening chemist-shops in government and private hospitals at least in big cities where branded medicines may be available even in single strips at 20-percent discounts. It is quite usual that many a times some medical-practitioners including in Unani, Ayurvedic and Homeopathic fields mix strong doses of allopathic steroids in unbranded medicines like powders and syrups in a bid to exhibit their self-acclaimed expertise in curing diseases. Only branded medicines should be allowed to be prescribed in all fields of medicines including Allopathic, Ayurvedic, Unani, Homeopathy with Central Government having its large production-units for very type of medicines by reviving Indian Drugs & Pharmaceuticals Limited (IDPL) in a big way and popularising and extending scope of its Ayurvedic unit Indian Medicines Pharmaceuticals Corporation Limited to develop a healthy competition to force big drug-companies to bring down heavily prices of branded medicines. Central Information Commission (CIC) in its order dated 01.10.2018 in file-number CIC/NPPAT/A/2017/152869-BJ recommended NPPA and others concerned to consider all these suggestions in larger public interest. But shockingly, NPPA challenged the CIC-decision just on recommendations (and not directions) at Delhi High Court vide WP(C) 10366 of 2019 and CM No. 42777 of 2019. Soon after Competition Commission of India (CCI) in its policy-note also pointed out towards unreasonably high trade-margins as reason for exorbitant drug-prices. But no corrective measures are seen at least on non-essential and generic medicines. BJP MP Bhartruhari Mahtab raised issue of generic drugs in Lok Sabha on 19.07.2019, rightly demanding an inquiry to find out the efficacy of generic drugs quoting a book-study that Indian drug manufacturers were producing quality generic medicines for US and European countries with sub-standard generic medicines marketed in domestic market. NPPA should ensure that generic medicines sold in Indian markets are of export-quality. Export of world-class generic medicines can provide country adequate foreign-exchange and reputation because of Indian generic medicines are economical than foreign-branded medicines of which major part is royalty of drug-manufacturing companies. Lucknow bench of Allahabad High Court in the year 2018 imposed fine on three doctors for illegible hand-writing on injury-reports. Odisha High Court on 13.

08.2020 advised doctors to write legible prescriptions preferably in capital letters. Medical-practitioners should compulsorily issue computerised prescriptions. Exemption may be for aged ones not familiar to use computers. Union Health Ministry should develop user-friendly soft-wares separately for hospitals, pathological laboratories and medical practitioners providing unique ID for each patient so that complete medical history may be available even online to the patient.   Dual pricing must not be allowed in health-services including for pathological and biochemical tests for normal patients and those covered under Central Government Health scheme (CGHS). Vegetarian cellulose capsules should be encouraged to replace non-vegetarian gelatin capsules presently having 98-percent market share to respect sentiments of majority vegetarian population. Supreme Court ruling of the year 2013 had made it possible to distinguish vegetarian and non-vegetarian medicines by having green and red dots. Providing land at subsidised cost/lease is substantial government-funding. All such hospitals should be directed to sue-motto declare themselves as public-authorities under section 2(h) of RTI Act, or else pay market-price of land provided to these hospitals at current market rates. Union Health Ministry in the year 2018 banned 328 Fixed-Dose-Combination drugs out of total 349 recommended to be banned by Chandrashekhar Kokate Committee with six more allowed with restricted sale. Banned medicines included commonly advertised popular medicines like Saridon and Vicks-Action-500 which continued to be household names in India for last so many decades. Medicines considered harmful are banned in India years after these are banned in foreign countries. Union Health Ministry should take immediate decision once some medicine is banned in other countries. Action is necessary against celebrities advertising the popular medicines without having knowledge about the advertised medicines. There should be a total ban on advertisements of medicines in view of ban imposed on commonly advertised medicines. Reports were there in media with opinion of medical experts about artificial health-food and cosmetic surgery being possible reasons behind the cardiac-arrest responsible for sudden untimely death of Bollywood-superstar Shridevi (54) on night of 24.02.2018 at Dubai. Fast life-style has made youngsters to switch to costly gyms from natural walk. Trend of cosmetic surgery for looking beautiful and fit is also increasing with same pace. Union Health Ministry should set up an expert-committee to study after-effects of artificial health-food and cosmetic surgery, and only certified health-food should be permitted to be sold. Writer is RTI consultant holding Guinness World record for most letters published in newspaper

[janaushadhikendra]

Say goodbye to scalp fungal infections with Jan Aushadhi Ketoconazole shampoo. This medicinal shampoo not only treats dandruff and psoriasis but also other skin disorders. Get yours today at your nearest Jan Aushadhi Kendra and save high expenditure on your purchase. #PMBJP #janaushadhikendraadajan https://www.instagram.com/p/Cqi194nri6M/?igshid=NGJjMDIxMWI=